This news is covered by the Bureau present at the TCT Conference 2025, being held in San Francisco. San Francisco, October 2025:The opening session of Transcatheter Cardiovascular Therapeutics (TCT) 2025 set the tone for a new era in medical technology, emphasizing disruptive innovation as the driving force behind the future of healthcare transformation. Andrew Cleeland, CEO of Fogarty Innovation and a leading global advocate for clinician-led entrepreneurship, urged the medical community to look beyond incremental progress and focus on value based disruption. “Innovation alone is not enough. It’s about how we create value for patients, physicians, and systems — not just how we make the next shiny device,” said Cleeland, addressing a global audience of clinicians, innovators, and investors. The message captured a broader shift in the MedTech landscape, from high-cost, incremental improvements toward technologies and delivery models that democratize care, redefine access, and create measurable value for health systems. Defining Disruptive Innovation in Healthcare Coined by Harvard professor Clayton M. Christensen in the late 1990s, the term disruptive innovation describes solutions that begin as simpler, more affordable alternatives serving overlooked markets, eventually displacing established technologies or models. In healthcare, the principle evolves uniquely. Because patient safety and reliability are paramount, disruptive medical technologies must combine clinical rigor with cost efficiency and workflow transformation. Examples include: • Transcatheter valve replacement replacing open-heart surgery • AI-powered ECGs and CT angiography enabling non-invasive diagnostics • Remote cardiac monitoring and wearables bringing intensive care to patients’ homes • 3D printing and robotics minimizing surgical complexity and hospital stays These innovations represent not just new devices but entirely new systems of care delivery. From Incremental to Transformational Thinking While traditional MedTech progress has relied on incremental refinement — thinner stents, smarter catheters, faster scanners, disruptive innovation challenges the premise: why perform a procedure in the same way at all? Cleeland and the TCT faculty advocated for ecosystem-driven innovation, bringing clinicians, engineers, regulators, investors, and patients together early in the design process. Disruption today, they noted, is defined as innovation that creates value by removing barriers whether of complexity, cost, geography, or exclusivity. Key stages of MedTech disruption include: 1. Identifying unmet or underserved needs 2. Simplifying technology without compromising outcomes 3. Leveraging convergence of AI, data, and devices 4. Reimagining workflows to move care closer to patients 5. Achieving adoption across the healthcare ecosystem True disruption, Cleeland emphasized, depends on collaboration, not the myth of the lone inventor. “An idea by itself has no importance whatsoever; it’s the implementation and acceptance by others that brings true benefit to patients,” he said. The Challenge and Promise Ahead Healthcare’s regulatory and ethical complexity often slows disruption, yet post-pandemic realities, workforce shortages, cost constraints, and digital acceleration, are now driving systemic change. MedTech disruptors must demonstrate clinical efficacy, navigate reimbursement, and build stakeholder trust, making progress deliberate but sustainable. India’s Emerging Role in Global Disruption India, with its vast patient base and digital innovation ecosystem, is poised to lead the next wave of MedTech disruption. Opportunities lie in AI-enabled imaging, point-of-care diagnostics, telecardiology, and home-based chronic care. Cleeland’s message to clinician-entrepreneurs resonated strongly: “True innovation is disciplined imagination.” Emerging trends also point to business-model innovation like subscription-based imaging, device-as-a-service solutions, and cloud-integrated analytics, signaling a shift from devices to delivery models that expand access and affordability at scale. Reference:https://www.tctconference.com/